2nd Peking University Urology Academic Forum | Professor Chaohui Gu: Umbilical Artery Ligament Suspension—A New Breakthrough for Immediate Urinary Continence After Radical Prostatectomy

2nd Peking University Urology Academic Forum | Professor Chaohui Gu: Umbilical Artery Ligament Suspension—A New Breakthrough for Immediate Urinary Continence After Radical Prostatectomy

At the 2nd Peking University Urology Academic Forum and the 80th Anniversary Celebration of the Department of Urology at Peking University First Hospital, Oncology Frontier – UroStream  interviewed Professor Chaohui Gu from the Department of Urology, The First Affiliated Hospital of Zhengzhou University.
2nd Peking University Urology Academic Forum | Professor Wei Zhu: FANS Technology Revolutionizes Flexible Ureteroscopic Lithotripsy Through Clinician–Engineer Innovation

2nd Peking University Urology Academic Forum | Professor Wei Zhu: FANS Technology Revolutionizes Flexible Ureteroscopic Lithotripsy Through Clinician–Engineer Innovation

Flexible ureteroscopic lithotripsy is an important treatment modality for upper urinary tract stones. However, conventional procedures are associated with several limitations, including low stone-free rates, elevated intrarenal pressure during surgery, and increased risks of postoperative infection and ureteral stricture.
International Perspectives from EBMT | Professor Florent Malard: New Frontiers in Microbiome-Based Therapy for the Treatment and Prevention of Graft-versus-Host Disease

International Perspectives from EBMT | Professor Florent Malard: New Frontiers in Microbiome-Based Therapy for the Treatment and Prevention of Graft-versus-Host Disease

Graft-versus-host disease (GVHD) remains one of the most severe complications following hematopoietic stem cell transplantation. Among its manifestations, acute gastrointestinal GVHD is particularly challenging to manage. Despite standard therapies, a substantial proportion of patients fail treatment, and no approved therapeutic options currently exist for those with refractory disease, representing a major unmet medical need.
Professor Qingyuan Zhang: From Strategic Deployment of Novel Therapies to Integrated Care—Exploring New Survival Pathways in R/R DLBCL | 2026 CACA Western Integrated Oncology Conference

Professor Qingyuan Zhang: From Strategic Deployment of Novel Therapies to Integrated Care—Exploring New Survival Pathways in R/R DLBCL | 2026 CACA Western Integrated Oncology Conference

Amid the vibrant renewal of spring, the 2026 CACA Western Integrated Oncology Conference was grandly convened in Chengdu, Sichuan. The meeting brought together leading oncology experts from across China to explore the frontiers of precision oncology and advance integrated, whole-course cancer care.
AOT 2026 | Professor Xiaojun Huang Leads In-Depth Discussions on Three Major Controversies in Hematopoietic Stem Cell Transplantation

AOT 2026 | Professor Xiaojun Huang Leads In-Depth Discussions on Three Major Controversies in Hematopoietic Stem Cell Transplantation

Academic progress begins with debate and matures through consensus. As a cornerstone therapy for hematologic diseases, hematopoietic stem cell transplantation (HSCT) continues to face numerous unresolved controversies and clinical dilemmas. Centered on the theme “The Art of Transplantation,” the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT 2026) brought together leading experts from around the world to discuss technological innovation and future directions in transplantation medicine.
Professor Zhiming Li: Addressing the Challenges of NK/T-Cell Lymphoma with a China-Specific Approach | 2026 CACA Western Integrated Oncology Conference

Professor Zhiming Li: Addressing the Challenges of NK/T-Cell Lymphoma with a China-Specific Approach | 2026 CACA Western Integrated Oncology Conference

To further promote the expansion, equitable distribution, and accessibility of high-quality cancer care resources, and to enhance the academic and clinical capabilities of oncology care in western China and at the grassroots level, the 2026 CACA Western Integrated Oncology Conference was successfully held in Chengdu on April 18, 2026. The conference provided a high-level platform for academic exchange and translational collaboration in oncology.